Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma

Immunotherapy has been recently approved for the treatment of relapsed and metastatic human papilloma virus (HPV) positive and negative head and neck squamous cell carcinoma (HNSCC). However, the response of patients is limited and the overall survival remains short with a low rate of long-term surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Seliger, Barbara, Massa, Chiara, Yang, Bo, Bethmann, Daniel, Kappler, Matthias, Eckert, Alexander Walter, Wickenhauser, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582858/
https://www.ncbi.nlm.nih.gov/pubmed/32987799
http://dx.doi.org/10.3390/ijms21197032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582858/
https://www.ncbi.nlm.nih.gov/pubmed/32987799
http://dx.doi.org/10.3390/ijms21197032

Ejemplares similares